Global COVID-19 treatment trial shows current antivirals are of little benefit to hospitalized patients
Interim results from the Solidarity Therapeutics Trial indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
Oct 16, 2020
Canadian COVID-19 trial gets additional $3.5 million in federal funding
The Canadian arm of a major international clinical trial—led by a University of British Columbia researcher—that aims to find the best treatment for COVID-19 has received an additional $3.5 million in funding from the federal government through the Canadian Institutes of Health Research (CIHR).
May 28, 2020